Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial

INTRODUCTION: Treatment options for adults with attention deficit hyperactivity disorder (ADHD) are limited. The study was conducted to confirm the clinically effective and safe dose of methylphenidate hydrochloride modified-release (MPH-LA) in adults with ADHD and evaluate the maintenance of effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Huss, Michael, Ginsberg, Ylva, Tvedten, Torbjorn, Arngrim, Torben, Philipsen, Alexandra, Carter, Katherine, Chen, Chien-Wei, Kumar, Vinod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905180/
https://www.ncbi.nlm.nih.gov/pubmed/24371021
http://dx.doi.org/10.1007/s12325-013-0085-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905180/
https://www.ncbi.nlm.nih.gov/pubmed/24371021
http://dx.doi.org/10.1007/s12325-013-0085-5

Ejemplares similares